| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13D · 1 security · may seek to influence control | ||||||
|
STRATA Skin Sciences
13D/A
SSKN · 86272A305
|
27.4% |
9/5/2025
Event 9/4/2025
|
||||
| Accelmed Partners, L.P. | 27.4% | |||||
| Accelmed Partners (GP), L.P. | 27.4% | |||||
| Accelmed Growth Partners (AGP) Ltd. | 27.4% | |||||
| Accelmed Growth Partners Management Ltd. | 27.4% | |||||
| Uri Geiger | 27.4% | |||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.